GTCR Fund XI/C LP
- SEC CIK
- 0001591436
In the past year, 4 open-market sale filings worth $639.5M and no purchases.
Current role at each company
- SHC Sotera Health CoDirector, 10% Owneras of May 15, 2026
- MRVI Maravai Lifesciences Holdings, Inc.Director, 10% Owneras of May 30, 2024
- PAYA Paya Holdings Inc.Director, 10% Owneras of Feb 22, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $639.5M
- 4 filings
- Net
- −$639.5M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists GTCR Fund XI/C LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SHC Sotera Health Co
Director, 10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 (view filing)4:41 PM ET | May 13 | 2 days | GTCR Co-Invest XI LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −12.7M | $15.17 | −$193.2M | −100.0%0 after | |
| Mar 10, 2026 (view filing)6:10 PM ET | Mar 6 | 4 days | GTCR Co-Invest XI LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −10.0M | $15.27 | −$152.7M | −44.0%12.7M after | |
| Dec 5, 2025 (view filing)8:10 PM ET | Dec 3 | 2 days | GTCR Co-Invest XI LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −6.48M | $16.33 | −$105.8M | −22.2%22.7M after | |
| Nov 12, 2025 (view filing)5:06 PM ET | Nov 10 | 2 days | GTCR Co-Invest XI LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −12.0M | $15.65 | −$187.8M | −29.1%29.2M after | |
| Sep 9, 2025 (view filing)8:41 PM ET | Sep 5 | 4 days | GTCR Co-Invest XI LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −8.00M | $15.11 | −$120.9M | −16.3%41.2M after | |
| Sep 9, 2024 (view filing)5:36 PM ET | Sep 6 | 3 days | GTCR Co-Invest XI LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −10.0M | $15.03 | −$150.3M | −16.9%49.2M after | |
| Mar 6, 2024 (view filing)5:35 PM ET | Mar 4 | 2 days | GTCR Co-Invest XI LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −11.1M | $14.31 | −$158.3M | −15.7%59.2M after |
MRVI Maravai Lifesciences Holdings, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2024 (view filing)5:39 PM ET | May 28 | 2 days | GTCR Co-Invest XI LP and 7 othersDirector, 10% Owner | SSaleClass A common stock | −9.94M | $9.82 | −$97.6M | −33.0%20.2M after |